Jahangirifard Alireza, Hossein Ahmadi Zargham, Golestani Eraghi Majid, Tabarsi Payam, Marjani Majid, Moniri Afshin, Nadji Seyed Ali Reza, Hashemian Seyed Mohammad Reza, Velayati Ali Akbar
National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Tehran Heart Cent. 2016 Jul 6;11(3):153-156.
Respiratory failure is a serious complication of H1N1 influenza that, if not properly managed, can cause death. When mechanical ventilation is not effective, the only way to save the patient's life is extracorporeal membrane oxygenation (ECMO). A prolonged type of cardiopulmonary bypass, ECMO is a high-cost management modality compared to other conventional types and its maintenance requires skilled personnel. Such staff usually comprises the members of open-heart surgical teams. Herein, we describe a patient with H1N1 influenza and severe respiratory failure not improved by mechanical ventilation who was admitted to Masih Daneshvari Medical Center in March 2015. She was placed on ECMO, from which she was successfully weaned 9 days later. The patient was discharged from the hospital after 52 days. Follow-up till 11 months after discharge revealed completely active life with no problem. There should be a close collaboration among infectious disease specialists, cardiac anesthetists, cardiac surgeons, and intensivists for the correct timing of ECMO placement, subsequent weaning, and care of the patient. This team work was the key to our success story. This is the first patient to survive H1N1 with the use of ECMO in Iran.
呼吸衰竭是甲型H1N1流感的一种严重并发症,若处理不当可导致死亡。当机械通气无效时,挽救患者生命的唯一方法是体外膜肺氧合(ECMO)。ECMO是一种延长的体外循环方式,与其他传统方式相比,它是一种高成本的治疗手段,且其维护需要专业人员。这类人员通常包括心脏外科手术团队的成员。在此,我们描述一名2015年3月入住马西赫·达内什瓦里医疗中心的甲型H1N1流感患者,其因机械通气无法改善的严重呼吸衰竭而入院。她接受了ECMO治疗,并于9天后成功撤机。患者在52天后出院。出院后随访11个月显示其生活完全正常,没有问题。传染病专家、心脏麻醉师、心脏外科医生和重症监护医生之间应密切合作,以确定ECMO置入、随后撤机及患者护理的正确时机。团队协作是我们成功的关键。这是伊朗首例使用ECMO治疗甲型H1N1流感存活的患者。